EUVIMEDEUVIMED entdecken
Crossref

The Psychedelic Therapies Executive Order

I Glenn Cohen, Holly Fernandez Lynch, Amy L McGuire

JAMA · 04.08.2026 · 336 (5) · 367

DOI: 10.1001/jama.2026.11892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 04.08.2026. Verfasst von I Glenn Cohen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Law School, Cambridge, Massachusetts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint discusses the executive order supporting the development and approval of psychedelic drugs and outlines issues surrounding their ethical and evidence-based integration into clinical care.

Autor:innen und Institutionen

  • Harvard Law School, Cambridge, Massachusetts.
  • The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, Massachusetts.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas.

Zitieren

APA

Cohen, I. G., Lynch, H. F., & McGuire, A. L. (2026). The Psychedelic Therapies Executive Order. JAMA, 336(5), 367. https://doi.org/10.1001/jama.2026.11892

Vancouver

Cohen IG, Lynch HF, McGuire AL. The Psychedelic Therapies Executive Order. JAMA. 2026;336(5):367. doi:10.1001/jama.2026.11892

BibTeX
@article{Cohen2026,
  author = {Cohen, I Glenn and Lynch, Holly Fernandez and McGuire, Amy L},
  title = {The Psychedelic Therapies Executive Order},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {5},
  pages = {367},
  doi = {10.1001/jama.2026.11892}
}
Kostenlos starten →